Skip to main content
Signal8
GOLL JOHN profile photo

John Goll

CIK: 0001779466

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunocore Holdings plc logo
IMCR

Immunocore Holdings plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 18, 2026
    Sale(S)
    Direct
    698 shares at avg. $32.35$23K
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2026
    Exercise(M)
    Direct
    1.4K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2026
    Award(A)

    Restricted Share Units

    Direct
    7.4K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2026
    Award(A)

    Employee Share Option (Right to Buy)

    Direct
    21.3K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2025
    Award(A)

    Employee Share Option (Right to Buy)

    Direct
    14.8K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2025
    Award(A)

    Restricted Share Units

    Direct
    5.4K shares-

1-6 of 6

About GOLL JOHN

GOLL JOHN (SEC CIK 0001779466) files insider reports with the SEC as SVP, FINANCE & CAO of Immunocore Holdings plc (IMCR).

Signal8 holds 2 ownership filings by GOLL JOHN, all Form 4s, filed between Feb 19, 2025 and Feb 19, 2026. Those filings report 6 transactions, from Feb 17, 2025 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GOLL JOHN's filings is in ABINGDON, OXFORDSHIRE, X0.

Recent filings by GOLL JOHN

  • Feb 18, 2026: Open-market sale of IMCR shares (Form 4, code S).
  • Feb 17, 2026: Option exercise of IMCR shares (Form 4, code M).
  • Feb 17, 2026: Grants or awards of IMCR derivative securities (2 lines, Form 4, code A).
  • Feb 17, 2025: Grants or awards of IMCR derivative securities (2 lines, Form 4, code A).

Other insiders filing for Immunocore Holdings plc (IMCR)

How to read Form 4 transaction codes